1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Structural comparison of protiated, H/D-exchanged and deuterated human carbonic anhydrase IX
(
- Contribution to journal › Article
- 2015
-
Mark
Creating novel activated factor XI inhibitors through fragment based lead generation and structure aided drug design
(
- Contribution to journal › Article
- 2014
-
Mark
Lp(a) is not associated with diabetes but affects fibrinolysis and clot structure ex vivo
(
- Contribution to journal › Article
-
Mark
Proteolytic activation of the human epithelial sodium channel by trypsin IV and trypsin I involves distinct cleavage sites
(
- Contribution to journal › Article
- 2012
-
Mark
Discovery of 4-hydroxy-1,6-naphthyridine-3-carbonitrile derivatives as novel PDE10A inhibitors
(
- Contribution to journal › Article
-
Mark
Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents
(
- Contribution to journal › Article
- 2011
-
Mark
Serine proteases mediate inflammatory pain in acute pancreatitis
(
- Contribution to journal › Article
- 2007
-
Mark
Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia
(
- Contribution to journal › Article
-
Mark
Recombinant expression, purification, and kinetic and inhibitor characterisation of human site-1-protease
(
- Contribution to journal › Article
- 2006
-
Mark
Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down-regulating fibrinolysis
(
- Contribution to journal › Article